Gene · 406934
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of miRNAs in the development of Super-Tregs as a potential therapy for neurodegenerative diseases. | Front Immunol | 2026 | 41716393 | PubTator, text mining | PubMed |
| miRNA gene mutations commonly disrupt the proper functioning of miRNA genes. | Sci Adv | 2026 | 41706844 | PubTator, text mining | PubMed |
| Exercise-derived extracellular vesicles in oncology: a new frontier for translational nanomedicine. | J Transl Med | 2026 | 41606592 | PubTator, text mining | PubMed |
| Combining Anti-Inflammatory Drugs and Cell-Specific Expression-Suppression Reduces the Adjuvant Activity of mRNA-LNPs. | Mol Pharm | 2026 | 41492664 | PubTator, text mining | PubMed |
| Human fetal circulating factors from pregnancies complicated by obesity upregulate genes associated with pathological hypertrophy in neonatal rat cardiomyocytes. | Am J Physiol Heart Circ Physiol | 2026 | 41269698 | PubTator, text mining | PubMed |
| Germline or somatic mutations in genes encoding microRNAs as biomarkers predicting the risk of adult T-cell leukemia/lymphoma. | J Hum Genet | 2026 | 41111079 | PubTator, text mining | PubMed |
| Retraction: Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142. | Oncotarget | 2025 | 42664427 | PubTator, text mining | PubMed |
| Targeted therapy for liver cancer: Current status and future directions. | Bioimpacts | 2025 | 41716515 | PubTator, text mining | PubMed |
| Systematic review on biomarker potential of vitreous microRNA in retinal disease. | Front Ophthalmol (Lausanne) | 2025 | 41472886 | PubTator, text mining | PubMed |
| MicroRNA-142 improves IL1RAP CAR-T cell activity in acute myeloid leukemia. | J Hematol Oncol | 2025 | 41225489 | PubTator, text mining | PubMed |
| Global research trends in non-coding RNA and intestinal epithelial homeostasis: an integrated bibliometric analysis (2007-2024). | Hereditas | 2025 | 41107911 | PubTator, text mining | PubMed |
| The miRNA-immune axis in bladder cancer: systematic evidence for a new era of immunotherapy precision. | Front Immunol | 2025 | 41050687 | PubTator, text mining | PubMed |
| Epigenetic modifications of immune cells in rheumatoid arthritis. | Ann Med | 2025 | 40990388 | PubTator, text mining | PubMed |
| Comparative Analysis of Gene and MicroRNA Expression in Subcutaneous Adipose Tissue in Metabolically Healthy and Unhealthy Obesity. | Int J Mol Sci | 2025 | 40943138 | PubTator, text mining | PubMed |
| Limiting viral replication in hematopoietic cells delays Rift Valley fever virus disease progression in C57BL/6 mice. | J Virol | 2025 | 40920082 | PubTator, text mining | PubMed |
| Circular RNA RORβ regulates TGFβR1 in alcohol-induced fibroblast-to-myofibroblast differentiation. | Sci Rep | 2025 | 40897735 | PubTator, text mining | PubMed |
| MicroRNAs as prognostic and predictive biomarkers among chronic myeloid leukemia patients in Addis Ababa, Ethiopia. | Sci Rep | 2025 | 40883483 | PubTator, text mining | PubMed |
| The roles of non-coding RNAs (ncRNAs) in the function of leukemic stem cells (LSCs): a comprehensive review. | Discov Oncol | 2025 | 40853607 | PubTator, text mining | PubMed |
| Cancer stem cells in personalized therapy: mechanisms, microenvironment crosstalk, and therapeutic vulnerabilities. | Front Cell Dev Biol | 2025 | 40809695 | PubTator, text mining | PubMed |
| Cerebral ischemia-reperfusion injury: mechanisms and promising therapies. | Front Pharmacol | 2025 | 40766753 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406934/papers?page=2